Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2015 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 41 stocks in 2015 Q3, with total market value around $6.00B.
Baupost Group's top five holdings in 2015 Q3: CHENIERE ENERGY INC 18.24%, VIASAT INC(VSAT) 12.35%, ALCOA INC 8.41%, PIONEER NAT RES CO 8.38%, ANTERO RES CORP 5.68%.
- Portfolio Value
- $6.00B
- Current Holdings
- 41 stocks
- New / Increased
- 9 / 10
- Reduced / Exited
- 4 / 0
Current Holdings
| 1 | CHENIERE ENERGY INCCUSIP 16411R208 | 1.09 | 18.24% | 22.67 +47.54% | $48.30 | - | $45.36 | +7.30 | 1.75 | +$0.07B+6.49% | Increased |
| 2 | VIASAT INCVSAT | 0.74 | 12.35% | 11.53 - | $64.29 | - | $71.14 | 0.00 | 2.50 | -$0.08B-9.63% | Held |
| 3 | ALCOA INCCUSIP 013817101 | 0.50 | 8.41% | 52.27 | $9.66 | - | $9.66 | +52.27 | 0.25 | $0.00B0.00% | New |
| 4 | PIONEER NAT RES COCUSIP 723787107 | 0.50 | 8.38% | 4.14 +1.77% | $121.64 | - | $157.39 | +0.07 | 0.75 | -$0.15B-22.72% | Increased |
| 5 | ANTERO RES CORPCUSIP 03674X106 | 0.34 | 5.68% | 16.10 +100.67% | $21.16 | - | $10.55 | +8.08 | 1.25 | +$0.17B+100.57% | Increased |
| 6 | PayPal Holdings, Inc.PYPL | 0.34 | 5.64% | 10.90 | $31.04 | $45.76 +47.41% | $31.04 | +10.90 | 0.25 | +$0.16B+47.41% | New |
| 7 | PBF ENERGY INCCUSIP 69318G106 | 0.31 | 5.19% | 11.03 - | $28.23 | - | $26.47 | 0.00 | 2.25 | +$0.02B+6.64% | Held |
| 8 | EBAY INC. COMEBAY | 0.23 | 3.79% | 9.31 - | $24.44 | - | $53.32 | 0.00 | 1.50 | -$0.27B-54.17% | Held |
| 9 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 0.18 | 2.94% | 6.53 | $27.07 | - | $27.07 | +6.53 | 0.25 | $0.00B0.00% | New |
| 10 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.17 | 2.81% | 5.36 +11.44% | $31.44 | - | $31.84 | +0.55 | 1.00 | -$0.00B-1.26% | Increased |
| 11 | THERAVANCE INCCUSIP 88338T104 | 0.14 | 2.37% | 19.82 - | $7.18 | - | $38.32 | 0.00 | 2.50 | -$0.62B-81.26% | Held |
| 12 | FORWARD PHARMA A/SCUSIP 34986J105 | 0.13 | 2.11% | 5.37 - | $23.56 | - | $20.83 | 0.00 | 1.00 | +$0.01B+13.11% | Held |
| 13 | OLIN CORPCUSIP 680665205 | 0.12 | 1.96% | 7.00 | $16.81 | - | $16.81 | +7.00 | 0.25 | $0.00B0.00% | New |
| 14 | TWENTY FIRST CENTY FOX INC CL AFOXA | 0.11 | 1.84% | 4.10 | $26.98 | - | $26.98 | +4.10 | 0.25 | $0.00B0.00% | New |
| 15 | VERITIV CORPCUSIP 923454102 | 0.10 | 1.73% | 2.80 +12.63% | $37.24 | - | $47.61 | +0.31 | 1.25 | -$0.03B-21.78% | Increased |
| 16 | AERCAP HOLDINGS NV SHSAER | 0.09 | 1.56% | 2.45 | $38.24 | $134.37 +251.39% | $38.24 | +2.45 | 0.25 | +$0.24B+251.39% | New |
| 17 | SUNEDISON SEMICONDUCTOR LTDCUSIP Y8213L102 | 0.09 | 1.47% | 8.37 +0.90% | $10.54 | - | $20.87 | +0.07 | 1.50 | -$0.09B-49.50% | Increased |
| 18 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.08 | 1.41% | 25.79 - | $3.28 | - | $14.16 | 0.00 | 1.75 | -$0.28B-76.86% | Held |
| 19 | NOVAGOLD RES INCCUSIP 66987E206 | 0.08 | 1.30% | 21.69 - | $3.61 | - | $2.11 | 0.00 | 2.50 | +$0.03B+71.09% | Held |
| 20 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.07 | 1.18% | 6.42 - | $10.99 | - | $31.03 | 0.00 | 1.50 | -$0.13B-64.58% | Held |
| 21 | FRONTIER COMMUNICATIONS CORPCUSIP 35906A108 | 0.06 | 1.07% | 13.50 - | $4.75 | - | $4.95 | 0.00 | 0.50 | -$0.00B-4.04% | Held |
| 22 | CHIPMOS TECH BERMUDA LTDCUSIP G2110R114 | 0.06 | 1.03% | 3.75 +14.27% | $16.42 | - | $18.79 | +0.47 | 2.50 | -$0.01B-12.63% | Increased |
| 23 | KLX INCCUSIP 482539103 | 0.05 | 0.89% | 1.50 - | $35.74 | - | $38.54 | 0.00 | 0.75 | -$0.00B-7.27% | Held |
| 24 | CITIGROUP INCCUSIP 172967226 | 0.05 | 0.79% | 102.55 - | $0.46 | - | $0.75 | 0.00 | 2.50 | -$0.03B-38.55% | Held |
| 25 | LIFELOCK INCCUSIP 53224V100 | 0.04 | 0.65% | 4.46 | $8.76 | - | $8.76 | +4.46 | 0.25 | $0.00B0.00% | New |
Showing 1-25 of 41
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.